VENUSREM logo

Venus Remedies Limited

VENUSREM·NSE·
1,602.90 -60.70 (-3.65%)
Market Cap2157.88 Cr
PE Ratio20.84
Volume25,257
Day High - Low1650.00 - 1586.00
52W High-Low2044.30 - 424.00
DocStoX Score
6.1/10
Fair
Fair Value
Sign in to see
ROE
16.80%
Strong
P/E
20.84x
Fair
Debt / Equity
0.02
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Fair

Price performance

Day1586
1650
52W424.00
2044
DocStoX take

Supported by momentum (7.5) and quality (7.3), but held back by valuation (3.7).

DocStoX score

Low confidence
6.1
/10
Fair
Quality
Solid
ROE 16.8%
Valuation
Rich
P/E 20.8×
Growth
Slow
Revenue +7.2% 5Y CAGR
Risk
Moderate
D/E 0.02
Momentum
Strong
73% of 52-week range

At a glance

Market Cap
₹2,158 Cr
52W High / Low
₹2044 / ₹424
Dividend Yield
0.63%
Promoter Holding
41.76%
EPS (TTM)
₹76.90
Book Value
₹497.00

Key highlights

  • Low leverage — D/E 0.02
  • Profitable in all of the last 5 years
  • Capital works hard — ROCE 22%
3 Positives0 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

VENUS REMEDIES LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.